NewsBenzingaTiziana Life Sciences Says First Three Participants Receive First Dose Of Intranasal Foralumab In Phase 2a Healey ALS Mymatch BANYAN Clinical Trial Tiziana Life Sciences Says First Three Participants Receive First Dose Of Intranasal Foralumab In Phase 2a Healey ALS Mymatch BANYAN Clinical Trial Benzinga 2026.09.28 11:09 (GMT+0) Open on Benzinga Other news JPMorgan Extends JPM Coin to Ethereum for Institutional Clients Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone Fifth Third Bancorp, Cleveland-Cliffs and 3 Stocks to Watch Heading Into Monday WGMI’s Pivot: From Bitcoin Miner To AI Power Play (Upgrade) (NASDAQ:WGMI) Weekly Market Pulse: Reality Bites (null:SPX) Exelon: Shelter From The Storm And Nice Yield As Utilities Catch A Bid (NASDAQ:EXC)
Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
